HLF vs. USNA, NUS, NATR, MED, VERU, EL, PBH, IPAR, COSM, and HWH
Should you be buying Herbalife stock or one of its competitors? The main competitors of Herbalife include USANA Health Sciences (USNA), Nu Skin Enterprises (NUS), Nature's Sunshine Products (NATR), Medifast (MED), Veru (VERU), Estée Lauder Companies (EL), Prestige Consumer Healthcare (PBH), Inter Parfums (IPAR), Cosmos Health (COSM), and HWH International (HWH).
Herbalife vs.
Herbalife (NYSE:HLF) and USANA Health Sciences (NYSE:USNA) are both small-cap retail/wholesale companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, community ranking, analyst recommendations, earnings, risk, valuation, institutional ownership and media sentiment.
54.3% of USANA Health Sciences shares are held by institutional investors. 1.7% of Herbalife shares are held by company insiders. Comparatively, 0.3% of USANA Health Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Herbalife had 17 more articles in the media than USANA Health Sciences. MarketBeat recorded 20 mentions for Herbalife and 3 mentions for USANA Health Sciences. Herbalife's average media sentiment score of 0.62 beat USANA Health Sciences' score of -0.44 indicating that Herbalife is being referred to more favorably in the media.
Herbalife has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Comparatively, USANA Health Sciences has a beta of 0.98, suggesting that its share price is 2% less volatile than the S&P 500.
Herbalife received 318 more outperform votes than USANA Health Sciences when rated by MarketBeat users. Likewise, 67.26% of users gave Herbalife an outperform vote while only 60.36% of users gave USANA Health Sciences an outperform vote.
USANA Health Sciences has a net margin of 6.30% compared to Herbalife's net margin of 5.09%. USANA Health Sciences' return on equity of 10.64% beat Herbalife's return on equity.
Herbalife has higher revenue and earnings than USANA Health Sciences. Herbalife is trading at a lower price-to-earnings ratio than USANA Health Sciences, indicating that it is currently the more affordable of the two stocks.
Herbalife presently has a consensus target price of $12.00, suggesting a potential upside of 48.24%. USANA Health Sciences has a consensus target price of $36.00, suggesting a potential upside of 32.23%. Given Herbalife's stronger consensus rating and higher probable upside, equities analysts clearly believe Herbalife is more favorable than USANA Health Sciences.
Summary
Herbalife beats USANA Health Sciences on 12 of the 18 factors compared between the two stocks.
Get Herbalife News Delivered to You Automatically
Sign up to receive the latest news and ratings for HLF and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Herbalife Competitors List
Related Companies and Tools
This page (NYSE:HLF) was last updated on 3/25/2025 by MarketBeat.com Staff
Buy HLF Stock Free HLF Stock Alerts